IVF Medication

The procurement process titled "IVF Medication" was conducted by the Swansea Bay University Health Board, based in Port Talbot, United Kingdom. This contract falls within the health services industry category and is specifically for the payment of medication for self-funded patients requiring IVF treatments. The procurement method used was a direct award, deemed necessary due to the urgency to ensure uninterrupted medication provision.

The process has reached the award stage, with a contract period from 19th May 2025 to 30th May 2025. Key dates include the award notice publication on 6th May 2025 and the future signature milestone scheduled for 7th May 2025. This procurement of IVF medication offers significant growth opportunities for businesses within the health services sector, particularly those capable of supplying urgent medical needs.

Pharmasure Ltd, a large-scale supplier located in Watford, was awarded the contract, demonstrating the potential for similar scale companies to position themselves as reliable providers for critical health-related contracts. Businesses specialising in pharmaceuticals or those willing to rapidly respond to urgent health supply needs would be well-suited to compete for future opportunities from organisations like the Swansea Bay University Health Board.